Global Melanoma Drugs Market 2018-2028

Global Melanoma Drugs Market 2018-2028
A new report by visiongain calculates that the global melanoma drugs market will reach $89bn in 2018 with revenues showing growth to 2028. These revenue forecasts and others appear in visiongain’s latest report Global Melanoma Drugs Market 2018-2028: By Kinase Inhibitors, By Immunotherapeutic Agents, By Chemotherapeutic Agents, Tafinlar, Mekinist, Zelbroaf, Yervoy, Proleukin, Keytruda, PegIntron, Roferon-A, ...

Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class , Drug Class & By Region Plus Analysis of Leading Companies

Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class , Drug Class  & By Region Plus Analysis of Leading Companies
LONDON, UK. 29th January 2018: Visiongain has launched a new pharma report Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class (Oncology, Alimentary Tract & Metabolism, Hormonal Disorders & Haematology, Neuroscience, Respiratory, Cardiovascular, Nephrology and Ophthalmology), Drug Class (Biologic, Small Molecule) & By Region Plus Analysis of Leading Companies An orphan disease is ...

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs
LONDON, UK. October 2017: Visiongain has launched a new pharma report Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs. The Latin American pharmaceutical market accounts for 8% of the global pharmaceutical industry, and is one of its fastest growing markets. Macroeconomic conditions ...

World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs

World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs
LONDON, UK. SEPTEMBER 2017: Visiongain has launched a new pharma report World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs. The future of the anti-cancer drugs market looks promising, as a number of new and innovative therapies are coming on to the market. In recent years there has been a ...

Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists, Long-acting Beta-Agonists, Long-acting Muscarinic Antagonists, Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs

Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists, Long-acting Beta-Agonists, Long-acting Muscarinic Antagonists, Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs
LONDON, UK. September 2017: Visiongain has launched a new pharma report Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists (SABAs), Long-acting Beta-Agonists (LABAs), Long-acting Muscarinic Antagonists (LAMAs), Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs The asthma & COPD market is maturing with generic competition looming for Advair, Symbicort, Spiriva and ...

Global Cholesterol-Lowering Drugs Market 2017-2027: Statins and Fixed-Dose Combinations, Cholesterol Absorption Inhibitors, Ion Exchange Resins, Fibrates, PCSK9 Inhibitors, Novel Drugs

Global Cholesterol-Lowering Drugs Market 2017-2027: Statins and Fixed-Dose Combinations, Cholesterol Absorption Inhibitors, Ion Exchange Resins, Fibrates, PCSK9 Inhibitors, Novel Drugs
LONDON, UK. August 2017: Visiongain has launched a new pharma report Global Cholesterol-Lowering Drugs Market 2017-2027: Statins and Fixed-Dose Combinations, Cholesterol Absorption Inhibitors, Ion Exchange Resins, Fibrates, PCSK9 Inhibitors, Novel Drugs Shifting diets and lifestyle choices are associated with increases in wealth and the level of development of a country’s economy. With the rapid growth ...

Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies

Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies
Visiongain’ has launched a new pharma report Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies Brazil’s pharmaceutical market is the eighth largest in the world, and is growing at a faster rate than many of the markets in developed countries. Between 2005 ...

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
Visiongain’ has launched a new pharma report Anti- Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others The potential of the OTC pharmaceutical market remains significant and it is a growing segment in the largely stagnant overall pharmaceutical market. In the face of looming patent ...

Non-Small Cell Lung Cancer (NSCLC) Drugs Market Forecast 2017-2027: Chemotherapy, EGFR and ALK Inhibitors, VEGF/VEGFR Inhibitors, Immunotherapy, Other

Non-Small Cell Lung Cancer (NSCLC) Drugs Market Forecast 2017-2027: Chemotherapy, EGFR and ALK Inhibitors, VEGF/VEGFR Inhibitors, Immunotherapy, Other
LONDON, UK June 2017: Visiongain’s new report Non-Small Cell Lung Cancer (NSCLC) Drugs Market Forecast 2017-2027: Chemotherapy, EGFR and ALK Inhibitors, VEGF/VEGFR Inhibitors, Immunotherapy, Other indicates that the non-small cell lung cancer drugs market will see $9.37bn in spending in 2021. The Non-Small Cell Lung Cancer (NSCLC) Drugs market is estimated at $7.86bn in 2016 ...

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs
LONDON, UK June 2017: Visiongain’s new report Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs indicates that the global ophthalmic drugs market will see $28.1bn in spending in 2021. The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in ...